5407972025-10-012025-12-315407972025-12-315407972025-04-012025-12-315407972025-10-012025-12-31in-capmkt:OtherExpenses1Member5407972025-10-012025-12-31in-capmkt:OtherExpenses2Member5407972025-10-012025-12-31in-capmkt:OtherExpenses3Member5407972025-04-012025-12-31in-capmkt:OtherExpenses1Member5407972025-04-012025-12-31in-capmkt:OtherExpenses2Member5407972025-04-012025-12-31in-capmkt:OtherExpenses3Member5407972025-10-012025-12-31in-capmkt:ReportableSegments1Member5407972025-10-012025-12-31in-capmkt:ReportableSegments2Member5407972025-04-012025-12-31in-capmkt:ReportableSegments1Member5407972025-04-012025-12-31in-capmkt:ReportableSegments2Member5407972025-10-012025-12-31in-capmkt:ReportableSegments1Member5407972025-10-012025-12-31in-capmkt:ReportableSegments2Member5407972025-04-012025-12-31in-capmkt:ReportableSegments1Member5407972025-04-012025-12-31in-capmkt:ReportableSegments2Member5407972025-10-012025-12-31in-capmkt:ReportableSegments1Member5407972025-12-31in-capmkt:ReportableSegments1Member5407972025-10-012025-12-31in-capmkt:ReportableSegments2Member5407972025-12-31in-capmkt:ReportableSegments2Member5407972025-10-012025-12-31in-capmkt:ReportableSegments1Member5407972025-12-31in-capmkt:ReportableSegments1Member5407972025-10-012025-12-31in-capmkt:ReportableSegments2Member5407972025-12-31in-capmkt:ReportableSegments2Member5407972025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15407972025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15407972025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15407972025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares540797SHALBYNOTLISTEDINE597J01018SHALBY LIMITEDMain BoardEquity2025-04-012026-03-312026-02-112026-02-02INRMillionsQuarterlyThird quarterMulti segment2026-02-1117:58:002026-02-1118:45:00Not applicable2025-10-012025-12-31UnauditedConsolidated2721260000722800002793540000176880000321340000-154820000470170000106410000176100000160516000027012400009230000009230000071730000779000079520000012780000000012780000-28120000-1534000017648000-4877000-2812200020001075170000100.120.12000.120.12Notes to the Unaudited Consolidated Financial Results for the Quarter & Nine months ended December 31, 2025 <BR> <BR> 1. The above unaudited consolidated financial results for the quarter and nine months ended December 31, 2025 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the company at their respective meetings held on February 11, 2026. The Statutory Auditors of the Company have carried out a Limited Review for said unaudited financial results. <BR> <BR> 2. These financial results have been prepared in accordance with Indian Accounting Standards (Ind- AS) as prescribed under section 133 of Companies Act 2013 read with Rule 3 of the Companies (Indian Accounting Standards) Rules 2015 and relevant amendment thereafter. <BR> <BR> 3. Shalby Limited Employees Welfare Trust has acquired 7,00,000 Equity Shares of Shalby Limited in June 2022 through market purchase pursuant to Employee Stock Option Scheme-2021. Company has granted all 7,00,000 Stock Options to eligible employees, out of which total 4,35,765 Stock Options were lapsed, 2,09,235 Options were vested and 2,08,235 Options exercised by eligible employees as on December 31, 2025 <BR> <BR> In accordance with the resolution passed by the Nomination and Remuneration Committee, the Company has granted 1,16,000 stock options from the pool of 4,35,765 lapsed options and as of December 31, 2025, a total of 56,000 stock options remain active. <BR> <BR> 4. The consolidated financial result includes the results of the Company, Shalby Limited and 14 Subsidiary companies (Covering 4 stepdown subsidiaies). The company together with its subsidiaries is herein referred to as the "Group" viz Shalby (Kenya) Limited, Vrundavan Shalby Hospitals Limited, Yogeshwar Healthcare Limited, Shalby International Limited, Griffin Mediquip LLP, Shalby MedTech Limited (formerly known as Mars Medical Devices Limited), Slaney Healthcare Private Limited, Shalby Hospitals Mumbai Private Limited, PK Healthcare Private Limited, Healers Hospital Private Limited, Shalby Advanced Technologies INC., Shalby Global Technologies Pte Ltd., Ningen Lifecare Private Limited and Shalby Advanced Technologies India Private Limited <BR> <BR> 5. The Group is not a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P /2018/144 dated November 26, 2018. <BR> <BR> 6. On November 21, 2025, the Government of India notified provisions of the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, ('Labour Codes') which consolidate twenty nine existing labour laws into a unified framework governing employee benefits during employment and post- employment. <BR> <BR> Based on management’s assessment, the implementation of the Labour Codes has not resulted in any material financial impact on the Group’s defined benefit obligations as at the reporting date. Accordingly, no adjustment has been recognised in the financial statements for the current quarter and the nine months ended 31st December, 2025. The Group continues to monitor the finalisation of the Central and State Rules, as well as further clarifications from the Government on various aspects of the Labour Codes, and will recognise any impact, if applicable, based on future developments. <BR> <BR> 7. As per Indian Accounting Standard ("Ind AS") 108 - "Segment Reporting", segment information has been provided in Consolidated Financial Results. The business segments of the company comprise of Healthcare Activities & Manufacturing of Implant. Disclosure for the same is given in the separate note attached herewith in Annexure I. <BR> <BR> 8. Previous period figures have been re-grouped, re-cast and re-arranged wherever considered necessary to make it comparable.2025-04-012025-12-31UnauditedConsolidated85398400001871100008726950000498510000926890000-3472000001387330000296570000515020000494026000082173800005095700000509570000397920000-5068000034724000001623300000000162330000-10317000059160000190700000-28377000-103181000110001075170000101.511.51001.511.51Other Expenses346100000Fees to Doctors and Consultants668800000Other Operative Exp590260000Other Expenses989770000Fees to Doctors and Consultants2059400000Other Operative Exp1891090000a) Healthcare Services2419750000b) Manufacturing & Trading of Implants301510000a) Healthcare Services7629050000b) Manufacturing & Trading of Implants9107900002721260000853984000027212600008539840000a) Healthcare Services200440000b) Manufacturing & Trading of Implants-108140000a) Healthcare Services782060000b) Manufacturing & Trading of Implants-27249000092300000509570000000092300000509570000a) Healthcare Services12235850000b) Manufacturing & Trading of Implants550748000017743330000017743330000a) Healthcare Services-4130340000b) Manufacturing & Trading of Implants-3597610000-77279500000-7727950000Remeasurement of the defined benefit plans-780000-780000Remeasurement of the defined benefit plans-2350000-2350000-270000-820000(Gain)/ Loss arising from translating the financial statement of foreign Operation-27610000-27610000(Gain)/ Loss arising from translating the financial statement of foreign Operation-101640000-10164000000-28120000-103170000